Abbott Laboratories (ABT)

Net Receivables

$8.60B

Quarterly · Period ending: · USD

ABT logo

ABT Net Receivables

Latest reported$8.60B
ABT Quarterly Net Receivables ($563.30M → $8.60B)
High-resolution chart · PNG

ABT net receivables history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Abbott Laboratories Net Receivables — Quarterly (USD)
Period endingNet Receivables (USD)
2,490,833,000
2,553,814,000
2,179,451,000
2,029,970,000
2,040,877,000
1,941,480,000
2,055,839,000
1,883,498,000
1,909,378,000
1,983,431,000
1,955,900,000
1,732,647,000
1,759,497,000
1,701,232,000
1,782,300,000
1,700,113,000
1,728,669,000
1,731,197,000
1,708,800,000
1,549,738,000
1,643,909,000
1,562,321,000
1,563,038,000
1,470,651,000
1,518,773,000
1,548,935,000
1,468,519,000
1,472,024,000
1,433,592,000
1,350,307,000
1,336,222,000
1,320,200,000
1,331,500,000
1,345,400,000
1,244,400,000
1,300,600,000
1,176,100,000
1,166,600,000
1,150,900,000
1,042,300,000
1,051,400,000
1,130,900,000
1,070,200,000
1,026,800,000
986,100,000
918,600,000
892,700,000
781,800,000
728,000,000
624,900,000
563,300,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.